Differences in accuracy of99mTc-sestamibi scanning between severe and mild forms of primary hyperparathyroidism

Journal of Nuclear Medicine Technology

Volumn 36, Issue 1, 2008, Pages 30-35

  Bandeira, Francisco A F ^a   Oliveira, Raíssa I R B ^a,b   Griz, Luiz H M ^a   Caldas, Gustavo ^b   Bandeira, Cristina ^b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b Hospital Agamenon Magalhaes   (Brazil)

Author keywords

99mTc sestamibi; Accuracy; Hyperparathyroidism; Parathyroid

Indexed keywords

CALCIUM; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ACCURACY; ADULT; AGED; ALBRIGHT SYNDROME; ARTICLE; BONE DISEASE; CALCIUM BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; PARATHYROID HORMONE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; MIDDLE AGED; PARATHYROID GLAND; SCINTISCANNING;

AGED; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; KIDNEY CALCULI; MALE; MIDDLE AGED; OSTEITIS FIBROSA CYSTICA; PARATHYROID GLANDS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI;

EID: 42049111664     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnmt.107.044040     Document Type: Article

References (27)

1. Kettle AG, O'Doherty MJ. Parathyroid imaging: how good is it and how should it be done? Semin Nucl Med. 2006;36:206-211.
2. Bandeira F, Griz L, Caldas G, Bandeira C, Freese E. From mild to severe primary hyperparathyroidism: the Brazilian experience. Arq Bras Endocrinol Metabol. 2006;50:657-663.
3. Bandeira F, Griz L, Macedo G, et al. Characteristics of primary hyperparathyroidism in one institution in northeast Brazil [abstract]. Bone. 1998;5(suppl):380.
4. Bandeira F, Macedo G, Caldas G, Griz L, Faria M. Hiperparatiroidismo primário. In: Endocrinologia e Diabetes. Rio de Janeiro, Brazil: MEDSI; 2003:382-391.
5. Rao DS, Agarwal G, Talpos GB, et al. Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism: a global perspective. J Bone Miner Res. 2002;17(suppl 2):75-80.
6. Osmolski A, Osmolski R, Frenkiel Z, et al. Primary hyperparathyroidism: case report and review of the literature. Otolaryngol Pol. 2006;60:93-96.
7. Johnston LB, Carroll KE, Britton DG, et al. The accuracy of parathyroid gland in primary hyperparathyroidism using sestamibi radionuclide imaging. J Clin Endocrinol Metab. 1996;81:346-352.
8. O'Doherty MJ. Radionuclide parathyroid imaging. J Nucl Med. 1997;38:840-841.
9. Mitchell BK, Kinder BK, Cornelius E, Stewart AF. Primary hyperparathyroidism: preoperative localization using technetium-sestamibi scanning. J Clin Endocrinol Metab. 1995;80:7-10.
10. Ishibashi M, Nishida H, Hiromatsu Y, et al. Localization of ectopic parathyroid glands using technetium-99m sestamibi imaging: comparison with magnetic resonance and computed tomographic imaging. Eur J Nucl Med. 1997;24:197-201.
11. AACE/AAES Task Force on Primary Hyperparathyroidism. Position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract. 2005;11:49-54.
12. Bilezikian JP, Rubin M, Silverberg SJ. Asymptomatic primary hyperparathyroidism. N Engl J Med. 2004;350:1746-1751.
13. 99mTc-sestamibi scanning: upper neck versus lower neck lesions. Endocr Pract. 2004;10:472-477.
14. Mariani G, Gulec SA, Rubello D, et al. Preoperative localization and radioguided parathyroid surgery. J Nucl Med. 2003;44:1443-1458.
15. Bilezikian JP, Marcus R, Levine MA. Clinical presentation of primary hyperparathyroidism: India, Brazil, China. In: The Parathyroids: Basic and Clinical Concepts. 2nd ed. Amsterdam, The Netherlands: Elsevier Science; 2001:472.
16. Mishra SK, Agarwal G, Kar DK, et al. Unique clinical characteristics of primary hyperparathyroidism in India. Br J Surg. 2001;88:708-714.
17. Silverberg SJ, Shane E, Dempster DW, Bilezikian JP. The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am J Med. 1999;107:561-567.
18. Bussey AD, Bruder JM. Urinary calcium excretion in primary hyperparathyroidism: relationship to 25-hidroxyvitamin D status. Endocr Pract. 2005;11:37-42.
19. Bhansali A, Masoodi SR, Bhadada S, et al. Ultrasonography in detection of single and multiple abnormal parathyroid glands in primary hyperparathyroidism: comparison with radionuclide scintigraphy and surgery. Clin Endocrinol (Oxf). 2006;65:340-345.
20. Barczynski M, Golkowski F, Konturek A, et al. Technetium-99m-sestamibi subtraction scintigraphy vs. ultrasonography combined with a rapid parathyroid hormone assay in parathyroid aspirates in preoperative localization of parathyroid adenomas and in directing surgical approach. Clin Endocrinol (Oxf). 2006;65:106-113.
21. 99mTc-sestamibi scintigraphy: comparison between subtraction- and dual-phase technique. Nuklearmedizin. 2006;45:115-121.
22. Pons F, Torregrosa JV, Fuster D. Biological factors influencing parathyroid localization. Nucl Med Commun. 2003;24:121-124.
23. Duarte PS, Decker HH, Aldighieri FC, et al. The relation between serum levels of calcium and PTH and the positivity of parathyroid scintigraphy with sestamibi: analysis of 194 patients. Arq Bras Endocrinol Metabol. 2005;49:930-937.
24. Parikshak M, Castillo ED, Conrad MF, Talpos GB. Impact of hypercalcemia and parathyroid hormone level on the sensitivity of preoperative sestamibi scanning for primary hyperparathyroidism. Am Surg. 2003;69:393-398.
25. Palestro CJ, Tomas MB, Tronco GG. Radionuclide imaging of the parathyroid glands. Semin Nucl Med. 2005;35:266-276.
26. Seret A, Defrise M, Blocket D. 180 degree pinhole SPET with a titled detector and OS-EM reconstruction: phantom studies and potential clinical applications. Eur J Nucl Med. 2001;28:1836-1841.
27. 99mTc-MIBI planar double-phase (DP) scintigraphy in hyperparathyroid patients [abstract]. J Nucl Med. 2001;42(suppl): 325P.